Skip to content

Clinical trial of different treatments in shoulder dislocation

Comparison of reducing success and complication of shoulder dislocation with “Succinylcholine and Thiopental”, “Propofol and Fentanyl” and “Fentanyl and Midazolam” in Emergency Department

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201009264811N1
Enrollment
150
Registered
2012-04-28
Start date
2010-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Dislocation of shoulder joint. Condition 2: Dislocation of shoulder joint. Dislocation of shoulder joint Contusion of shoulder and upper arm

Interventions

Intervention 1: Protocol A consist of 20 mg Succinylcholine and 100 mg Thiopental. Intervention 2: Protocol B consist of 1-3 mg/Kg Propofol and 2-3 mg/Kg Fentanyl. Intervention 3: Protocol C consist o
Treatment - Drugs
Protocol A consist of 20 mg Succinylcholine and 100 mg Thiopental
Protocol B consist of 1-3 mg/Kg Propofol and 2-3 mg/Kg Fentanyl
Protocol C consist of 2-3 mg/Kg Fentanyl and 3-5 mg Midazolam

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Cases aged between 16 and 65 with anterior/posterior shoulder dislocation including those with avulsion fracture of the greater tuberosity or of the glenoid labrum who have referred to emergency department and signed a written informed consent. Exclusion criteria: Patients with physical status higher than II according to American Society of Anesthesiologists (ASA); cases with major fracture-dislocation; cases with other major trauma; history of drug abuse; intoxicated patients.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Success of reduction. Timepoint: after each reducing process. Method of measurement: physical examination and X-ray.

Secondary

MeasureTime frame
Complication. Timepoint: after reduction and each subsequesnt visit. Method of measurement: history, physical examination and X-ray.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Afshin Amini

Shahid Beheshti University of Medical Sciences

A.amini@sbmu.ac.ir+98 21 7755 8081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026